BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17057737)

  • 1. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
    Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
    Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells.
    Schmeck B; Moog K; Zahlten J; van Laak V; N'Guessan PD; Opitz B; Rosseau S; Suttorp N; Hippenstiel S
    Respir Res; 2006 Jul; 7(1):98. PubMed ID: 16834785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
    Kielosto M; Nummela P; Katainen R; Leaner V; Birrer MJ; Hölttä E
    Cancer Res; 2004 Jun; 64(11):3772-9. PubMed ID: 15172983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
    J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the c-Jun NH
    Fung TS; Liu DX
    Cell Death Dis; 2017 Dec; 8(12):3215. PubMed ID: 29238080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulatory effect of Smad7 gene on MAPK signal pathway in malignant transformation of immortalized human bronchial epithelial BEP2D cells].
    Wang L; Huo YY; Zhang KT; Wang Y; Xiang XQ; Hu YC; Yu G; Li G; Mi C; Wu DC
    Ai Zheng; 2005 Sep; 24(9):1080-4. PubMed ID: 16159429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 stimulates normal bronchial epithelial cell growth through induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
    Fan Y; Wang Y; Wang K
    Respir Res; 2015 Dec; 16():149. PubMed ID: 26684827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
    Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
    Song W; Ma Y; Wang J; Brantley-Sieders D; Chen J
    Cancer Res; 2014 May; 74(9):2444-54. PubMed ID: 24607842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
    Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway.
    Funakoshi-Tago M; Nagata T; Tago K; Tsukada M; Tanaka K; Nakamura S; Mashino T; Kasahara T
    Cell Signal; 2012 Nov; 24(11):2024-34. PubMed ID: 22750290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
    Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus.
    Hurd C; Waldron RT; Rozengurt E
    Oncogene; 2002 Mar; 21(14):2154-60. PubMed ID: 11948398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.